Effect of rutin against gastric esophageal reflux in experimental animals

References

• Argentieri DC, Ritchie DM, Ferro MP, et al. (1994). Tepoxallin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile. J Pharmacol Exp Ther 271:1399–408
   PubMed Web of Science ®Google Scholar
• Azpiroz F, Bouin M, Camilleri M, et al. (2007). Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 19:62–8
   PubMedGoogle Scholar
• Cantrell DA, Smith KA. (1984). The interleukin-2 T-cell system: a new cell growth model. Science 224:1312–6
   PubMed Web of Science ®Google Scholar
• Claiborne A. (1985). Catalase activity. In Greenwald RA, ed. CRS handbook of methods for oxygen radical research. Boca Raton: CRC Press; 283–84
   Google Scholar
• Donne ID, Rossi R, Giustarini D, et al. (2003). Protein carbonyl group as biomarker of oxidative stress. Clin Chim Acta 329:23–38
   PubMed Web of Science ®Google Scholar
• Ellman GL. (1995). Tissue sulphydryl groups. Anal Biochem Biophys 82:70–7
   Google Scholar
• Fathadi A, Fields J, Banan A, Keshavarzian A. (2002). Reactive oxygen species: are they involved in pathogenesis of GERD, Barret’s esophagitis and latter’s progression toward esophageal cancer. Am J Gastroenterol 97:22–6
   PubMedGoogle Scholar
• Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. (2002a). Diversity in the oesophageal phenotypic response to gastroesophageal reflux: immunological determinants. Gut 50:451–9
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. (2002b). Inflammatory gradient in Barrett’s esophagus: implications for disease complications. Gut 51:316–22
   PubMedGoogle Scholar
• Hussain T, Verma AR, Vijayakumar M, et al. (2009). Rutin, a natural flavonoid, protects against gastric mucosal damage in experimental animals. Asia J Trad Med 4:188–97
   Google Scholar
• Isomoto H, Nishi Y, Wang A, et al. (2004). Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 99:1063–8
   PubMedGoogle Scholar
• Kaithwas G, Majumdar DK. (2010). Evaluation of antiulcer and antisecretory potential of L. usitatissimum fixed oil and possible mechanism of action. Inflammopharmacology 18:137–45
   PubMedGoogle Scholar
• Kedika RR, Souza RF, Spechler SJ. (2009). Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 54:2312–7
   PubMed Web of Science ®Google Scholar
• Khinchi P, Saha S, Saraf SA, Kaithwas G. (2014). Combination therapy of gamma-aminobutyric acid derivative promotes proton pump inhibitor based healing of reflux esophagitis in animal model. Pharmacol Rep 66:165–8
   PubMedGoogle Scholar
• Laine L. (2004). Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs – nice or necessary. Rev Gastroenterol Disord 4:S33–41
   PubMedGoogle Scholar
• Nakamura Y, Ishimitsu S, Tonogai Y. (2000). Effects of quercetin and rutin on serum and hepatic lipid concentrations, fecal steroid excretion and serum antioxidant properties. J Health Sci 46:229–40
   Google Scholar
• Ohkawa H, Ohishi N, Yagi K. (1979). Assay of lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–8
   PubMed Web of Science ®Google Scholar
• Pelletier MJ, Lajeunesse D, Reboul P, Pelletier JP. (2003). Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62:501–9
   PubMedGoogle Scholar
• Pereira RS. (2006). Regression of gastro-esophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and amino acids: comparison with omeprazole. J Pineal Res 41:195–200
   PubMedGoogle Scholar
• Pesce F, Romano P, Barabinol A, et al. (1991). Scanning electron microscopy study of small bowel biopsies in chronic diarrhoea in childhood. Histol Histopath 6:25–36
   PubMedGoogle Scholar
• Ranjitkar S, Kaidonis JA, Smales RJ. (2012). Gastroesophageal reflux disease and tooth erosion. Int J Dent Article ID: 479850
   Google Scholar
• Renu N, Kaithwas G, Ramteke PW, Saraf SA. (2012). Effect of Linum Lusitatissimum (linseed/flaxseed) fixed oil on experimental esophagitis in albino rats. Acta Gastroenterologica Belg 75:331–5
   PubMedGoogle Scholar
• Rieder F, Cheng L, Harnett KM, et al. (2007). Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterol 132:154–65
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. (1968). Estimation of total protein bound and non-protein bound sulphydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–05
   PubMed Web of Science ®Google Scholar
• Shin YK, Sohn UD, Choi MS, et al. (2002). Effects of rutin and harmaline on rat reflux oesophagitis. Auton Autacoid Pharmacol 22:47–55
   PubMedGoogle Scholar
• Shukla K, Raj P, Kumar A, Kaithwas G. (2014). Effect of monotherapy and combination therapy of pantoprazole and aprepitant in gastric esophageal reflux bisease in albino rats. ScientificWorldJournal 183147
   Google Scholar
• Singh G, Singh AT, Abrahama A, et al. (2008). Protective effect of Terminalia arjuna against doxorubicin induced cardio toxicity. J Ethanopharmcol 117:123–9
   PubMed Web of Science ®Google Scholar
• Sokol CL, Barton GM, Farr AG, Medzhitov RA. (2008). Mechanism for the initiation of the Th2 response by an allergen. Nat Immunol 9:310–8
   PubMed Web of Science ®Google Scholar
• Souza RF, Huo X, Mittal V, et al. (2009). Gastro-oesophageal reflux might cause oesophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterol 137:1776–84
   PubMed Web of Science ®Google Scholar
• Stein HJ, Hinder RA, Oosthuizen MMJ. (1990). Gastric mucosal injury caused hemorrhagic shock and reperfusion: protective role of antioxidant glutathione. Surgery 108:467–74
   PubMedGoogle Scholar
• Sugimoto M, Nishino M, Kodaira C, et al. (2011). Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. World J Gastroenterol 17:1858–65
   PubMedGoogle Scholar
• Toner PG, Carr KE. (2005). Use of scanning electron microscopy in the study of the intestinal villi. J Pathol 97:611–7
   Google Scholar
• Wang YK, Hsu WH, Wang SSW, et al. (2013). Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract Article ID: 983653
   Google Scholar
• Yang C, Hsiu S, Wen K, et al. (2005). Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J Food Drug Anal 13:244–50
   Web of Science ®Google Scholar